Drug Resistance Mechanisms in Human Cancer Cells to Anticancer Drugs
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 30 May 2024 | Viewed by 114
Special Issue Editor
Interests: DNA chemistry; Drug-DNA interaction; G-quadruplex-interactive drugs; anticancer drug discovery; mechanism of actions of new anticancer drugs; transcription factors; DNA repair
Special Issue Information
Dear Colleagues,
The development of resistance to anticancer agents within human cancer cells remains an important area of scientific and clinical investigation. Cancer cells acquire resistance through various mechanisms. New capabilities for repairing DNA damage can arise in response to cytotoxic therapies. Targeted therapies may lose their efficacy due to mutations in the target proteins or epigenetic changes in the expression levels. Cancer cells may even develop mechanisms to inactivate drugs directly. Additionally, resistance arises over time as a result of new mutations. Even as some cells within a tumour remain susceptible to a given treatment, other cells may develop resistance and persist. As a result, a therapeutic strategy that is of interest in new cancer drug development is the use of small molecule inhibitors to target drug resistance mechanisms. This Special Issue, “Drug Resistance Mechanisms in Human Cancer Cells to Anticancer Drugs”, welcomes original research and review articles in the field with a focus on, but not limited to, the molecular and mechanistic basis for drug resistance mechanisms in human cancer cells, as well as new therapeutic strategies for countering these resistance mechanisms.
Dr. Daekyu Sun
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- targeted therapy
- combination therapy
- drug resistance
- resensitization
- DNA repair
- DNA damage response
- DNA repair inhibitors
- synthetic lethality
- chemoradiation
